To further substantiate our observation that RIG-I/MAVS pathway activation is required for Pam2ODN-induced antibacterial protection, we developed a similar model of pseudomonal pneumonia with reduced lethality (2 × 1010 CFU/mL vs. 2.5 × 109 CFU/mL) (29). The gene discussed is MAVS; the disease is pneumonia.